ArticleJCO global oncology2020

Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer.

Seema Gulia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.